CN105797032A - Medicinal composition for treating pulmonary tuberculosis - Google Patents
Medicinal composition for treating pulmonary tuberculosis Download PDFInfo
- Publication number
- CN105797032A CN105797032A CN201610351509.XA CN201610351509A CN105797032A CN 105797032 A CN105797032 A CN 105797032A CN 201610351509 A CN201610351509 A CN 201610351509A CN 105797032 A CN105797032 A CN 105797032A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- pulmonary tuberculosis
- pharmaceutical composition
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
Abstract
The invention discloses a medicinal composition for treating pulmonary tuberculosis. The medicinal composition is prepared from the following medicinal materials in parts by weight: 8-12 parts of cinnabar, 8-12 parts of radix stemonae, 8-12 parts of apricot kernels, 8-12 parts of panax ginseng, 8-12 parts of radix gentianae macrophyllae, 10-14 parts of mix-fried turtle shell, 10-14 parts of radix asparagi, 5-7 parts of radix astragali, 5-7 parts of radix platycodi, 8-12 parts of plantain herb, 8-12 parts of herba houttuyniae, 10-14 parts of rhizoma nelumbinis, 8-12 parts of cacumen biotae, 8-12 parts of raw lotus leaves, and 8-12 parts of radix sanguisorbae. The medicinal composition can be used for radically treating both male patients and female patients of all ages suffering from diabetes mellitus type pulmonary tuberculosis, primary pulmonary tuberculosis, hemo-disseminated pulmonary tuberculosis, infiltrative pulmonary tuberculosis, chronic fibro-cavitative pulmonary tuberculosis and tuberculous pleuritis efficiently and stably within a short time.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to treat phthisical pharmaceutical composition.
Background technology
Pulmonary tuberculosis is the pneumonia infection disease caused by mycobacterium tuberculosis, passes through respiratory infectious.
Healthy People infects tulase and might not fall ill, the only just morbidity when immunity of organisms declines.Lung is tied
Core is a kind of chronic infection, according to power, the difference of resistance of human body of Causative virus, in symptom
Performance the most just differs, in early days: feel weak, and comparison of getting up morning is tired out, and afternoon, performance was unable, evening
On the most uncontrollable excitement and cause insomnia, and become thin in the case of without other reason, time long
Between cough and expectoration, slowly aggravate sputum mixed with blood, dyspnea, fall asleep and WA occurs complete
Body night sweat, and whole body fatigue and weakness occur.And go out after body temperature fluctuation, noon or fatigue occur
Existing body temperature raises, even low grade fever, and with uncomfortable in chest, the phenomenon of chest pain.Women without gynaecopathia or
There is menoxenia or menolipsis in the situation of person's pregnancy.When developing into osteopyrexia and fever and feverish sensation in the palms and soles, face cheekbone
Rubescent, xerostomia desire for cold drinks, red tongue thready and rapid pulse, even lustreless complexion, Mental fatigue body is soft, coughs language micro-,
Indigestion and loss of appetite loose stool, abundant expectoration are the dilutest, anemophobia spontaneous perspiration, pale tongue with white fur have indentation, a large amount of spitting of bloods with cardiopulmonary
Nonfunction.
The current Western medicine having a lot of pulmonary tuberculosis to cure on the market or Chinese medicine, formula has complicated and simple,
Because the preparation of former medicine is different, curative effect more differs, existing Western medicine and Chinese medicine have Orally taken and externally, removal of lesions,
The Therapeutic Method such as chemotherapy, because being limited by substrate (carrier), effect without more preferable result, and
There is recurrent exerbation, it is impossible to cure the effect of normal person.
Summary of the invention
The technical problem to be solved in the present invention is the deficiency overcoming existing treatment tuberculosis drugs, it is provided that one
Plant the pharmaceutical composition that treatment pulmonary tuberculosis is had better effects.
In pharmaceutical composition of the present invention, the consumption of each component is that inventor draws through a large amount of practice summaries
, it is made up of the raw material of following weight parts:
Cinnabaris 8-12 part, Radix Stemonae 8-12 part, Semen Armeniacae Amarum 8-12 part, Radix Ginseng 8-12 part, Radix Gentianae Macrophyllae 8-12
Part, Carapax Trionycis (processed) 10-14 part, Radix Asparagi 10-14 part, Radix Astragali 5-7 part, Radix Platycodi (Radix Platycodonis) 5-7 part, Herba Plantaginis
8-12 part, Herba Houttuyniae 8-12 part, Nodus Nelumbinis Rhizomatis 10-14 part, Cacumen Platycladi 8-12 part, raw Folium Nelumbinis 8-12
Part, Radix Sanguisorbae 8-12 part.
Preferably, it is made up of the raw material of following weight parts:
10 parts of Cinnabaris, the Radix Stemonae 10 parts, 10 parts of Semen Armeniacae Amarum, Radix Ginseng 10 parts, Radix Gentianae Macrophyllae 10 parts, process Trionyx sinensis Wiegmann
First 12 parts, Radix Asparagi 12 parts, the Radix Astragali 6 parts, Radix Platycodi (Radix Platycodonis) 6 parts, Herba Plantaginis 10 parts, Herba Houttuyniae 10 parts,
Nodus Nelumbinis Rhizomatis 12 parts, Cacumen Platycladi 10 parts, raw 10 parts of Folium Nelumbinis, Radix Sanguisorbae 10 parts.
The dosage form of pharmaceutical composition of the present invention can be medicated wine, capsule, granule, pill, sheet
The dosage form that agent, decoction etc. are medically acceptable, their preparation method, supplementary product consumption press existing routine
Technique is carried out.
Present invention additionally comprises aforementioned pharmaceutical compositions application in phthisical medicine is treated in preparation.
Prescription of the present invention,
Monarch drug:
Cinnabaris: tranquilizing mind, dehumidifying heat, removing toxic substances, anticorrosion.
The Radix Stemonae: lung moistening, cough-relieving, parasite killing.Semen Armeniacae Amarum: relieving cough and asthma.
Radix Ginseng: invigorating qi and benefiting blood, eliminates general weakness, insomnia and dreamful sleep, cardiopalmus.
Carapax Trionycis (processed): control insufficiency of kidney-YANG, the wet antiperspirant of hectic fever, hyperactivity of YANG due to deficiency of YIN.
Nodus Nelumbinis Rhizomatis: dissipating blood stasis stops blooding, heavy haematemesis.
Ministerial drug:
Radix Gentianae Macrophyllae: wind-expelling pain-stopping, removes deficiency-heat.
Radix Asparagi: support lung yin and mend, kidney yang, xeropulmonary cough, fever due to yin deficiency, body fluid lacks.
The Radix Astragali: the gas of tonifying the lung spleen, promotes the production of body fluid and nourishes blood, inducing diuresis to remove edema, the stagnant blood stasis dispelling of row.
Radix Platycodi (Radix Platycodonis): control cough with copious phlegm, uncomfortable in chest not smooth, enhancing immunity, pre-ulcer.
Herba Plantaginis: diuresis, cough due to lung-heat, relievings asthma.
Herba Houttuyniae: heat-clearing and toxic substances removing, antibacterial, antiviral, enhancing immunity.
Cacumen Platycladi: clearing and antitussive, cooling blood for hemostasis.
Raw Folium Nelumbinis；Clearing away summer-heat and eliminating dampness, sending up the lucid YANG, cooling blood for hemostasis.
Radix Sanguisorbae；Wind-expelling pain-stopping, removes deficiency-heat.
Prescription of the present invention, to protect kidney, to protect the liver, spleen invigorating, control lung, reaches sterilization, parasite killing, dispels the wind and remove
Wet, cold expelling is the most sick, passages through which vital energy circulates is unimpeded, qi and blood circulation promotion, detoxify, eliminate the phlegm, clearing away heat and cooling blood, dehumidifying, expectorant
Eliminating stagnation, promote the production of body fluid nourish blood, stop blooding, cough-relieving, insomnia, dreaminess, feel depressed, absentminded, increase
Antiinflammatory and immunization, none example of traditional treatment process is not injury health body constitution and therapeutic process overflows
Long.
The present invention makes up a prescription simply so that lung treatment thoroughly without leaving over calcification point, makes pulmonary revert to nothing
Normal condition before disease, each corner of each fine cell of drug osmotic pulmonary, and to former for a long time
Have Western medicine, dependency drug resistance body constitution that Chinese medicine brings treats perfect result again.
No matter the present invention is to the pulmonary tuberculosis men and women of various age levels, fro diabetic pulmonary tuberculosis, essential
Pulmonary tuberculosis, hematogenous disseminated pulmonary tuberculosis, infiltrative pulmonary tuberculosis, chronic fibro cavernous pulmonary tuberculosis, knot
Nuclearity pleuritis can efficiently, the time is short, cure smoothly.
Detailed description of the invention
With specific embodiment, the invention will be further described below, but the invention is not limited in these
Embodiment.
Embodiment 1
Cinnabaris 80g, Radix Stemonae 120g, Semen Armeniacae Amarum 80g, Radix Ginseng 120g, Radix Gentianae Macrophyllae 80g, Carapax Trionycis (processed) 140g,
Radix Asparagi 100g, Radix Astragali 70g, Radix Platycodi (Radix Platycodonis) 50g, Herba Plantaginis 120g, Herba Houttuyniae 80g, Nodus Nelumbinis Rhizomatis 140g,
Cacumen Platycladi 80g, raw Folium Nelumbinis 120g, Radix Sanguisorbae 80g.
Weigh above each raw material, boiling twice by proportional quantity, add 7 times amount water for the first time, decoct
1.5 hours, second time added 8 times amount water, decocts 1.5 hours, collecting decoction, filtered, and filtrate is dense
It is reduced to the extractum that relative density is 1.30 (surveying when 70 DEG C), adds appropriate cane sugar powder, routinely work
Skill makes granule.
Embodiment 2
Cinnabaris 120g, Radix Stemonae 80g, Semen Armeniacae Amarum 120g, Radix Ginseng 80g, Radix Gentianae Macrophyllae 120g, Carapax Trionycis (processed) 100g,
Radix Asparagi 140g, Radix Astragali 50g, Radix Platycodi (Radix Platycodonis) 70g, Herba Plantaginis 80g, Herba Houttuyniae 120g, Nodus Nelumbinis Rhizomatis 100g,
Cacumen Platycladi 120g, raw Folium Nelumbinis 80g, Radix Sanguisorbae 120g.
Weigh above each raw material, boiling twice by proportional quantity, add 7 times amount water for the first time, decoct
1.5 hours, second time added 8 times amount water, decocts 1.5 hours, collecting decoction, filtered, and filtrate is dense
It is reduced to the extractum that relative density is 1.30 (surveying when 70 DEG C), adds the dextrin adjuvant of conventional amount used, press
Common process, makes capsule, 0.5g/ grain.
Embodiment 3
Cinnabaris 100g, Radix Stemonae 100g, Semen Armeniacae Amarum 100g, Radix Ginseng 100g, Radix Gentianae Macrophyllae 100g, Carapax Trionycis (processed)
120g, Radix Asparagi 120g, Radix Astragali 60g, Radix Platycodi (Radix Platycodonis) 60g, Herba Plantaginis 100g, Herba Houttuyniae 100g, Nodus Nelumbinis Rhizomatis
120g, Cacumen Platycladi 100g, raw Folium Nelumbinis 100g, Radix Sanguisorbae 100g.
Weigh above each raw material, after processing according to prior art, add 48 degree of soaking in Chinese liquor of 10 times amount
One month, filter, obtain medicated wine.
Experimental example: pharmaceutical composition of the present invention is to phthisical clinical efficacy
1 data and method
1.1 clinical data
Choose in January, 2012 to accept for medical treatment to Disease Control and Prevention Centers of in December, 2014 county and Partial Medical Institutions
90 example Pulmonary Tuberculosis Infection patients, be randomly divided into matched group and treatment group, often organize 45 examples, Qi Zhongsuo
Have patient all to meet the diagnosis of pulmonary tuberculosis standard that tuberculosis branch of Chinese Medical Association formulates, through iconography and
Lab testing all finds activeness pathological changes in pulmonary, has the expectorant acid fast bacteria inspection of 11 example patients to be positive.
In treatment group, male 25 example, women 20 example, age 22-73 year, the mean age (41 ±
1.5) year, course of disease 1-7, average course of disease (4.3 ± 1.9) year；20 examples are primary pulmonary tuberculosis,
25 example secondary pulmonary tuberculosis；Symptom: 11 example patients show as hemoptysis symptom, 10 examples show as weak,
Becoming thin, 12 examples show as heating and night sweat, and 8 examples show as chest pain and breathe hard, and 5 example patients merge knot
Conjunction property pleuritis；Sick position: 13 example patient's pathological changes are limited to 1 lung field, and 12 example patient's pathological changes are limited to two
To three lung fields, 20 example patient's pathological changes are limited to four to five lung fields.
In matched group, male 21 example, women 23 example, age 20-74 year, the mean age (39 ±
4.5) year, course of disease 1-8, average course of disease (5.1 ± 2.2) year；25 examples are primary pulmonary tuberculosis,
20 example secondary pulmonary tuberculosis；Symptom: wherein 18 example patients show as hemoptysis symptom, 11 examples show as
Weak, become thin, 7 examples show as heating and night sweat, and 8 examples show as chest pain and breathing hard, and 9 example patients close
And associativity pleuritis；Sick position: 20 example patient's pathological changes are limited to 1 lung field, 14 example patient's pathological changes limits
In two to three lung fields, 11 example patient's pathological changes are limited to four to five lung fields.
The basic document of two groups of patients, clinical symptoms and sick position scope compare, and its no statistical difference is anticipated
Justice (p > 0.05), has comparability.
1.2 Therapeutic Method
Matched group use classic chemotherapy Regimen Chemotherapy: wherein isoniazid: 0.3g/d, pyrazinamide:
1.5g/d, ethambutol: 0.75g/d, streptomycin: 0.75g/d.
Treatment group selection embodiment 3 medicated wine, each 20mL, 3 times/day.
By above scheme, matched group continued treatment 12 months was 1 course for the treatment of, treatment group continued treatment 1
Individual month was 1 course for the treatment of, the liver function of patient to be made regular check on during treatment.After 1 course for the treatment of, see
Examine clinical efficacy and the relapse rate of two groups of patients.
1.3 efficacy determination
Cure: the cough of patient, heating, hematemesis transference cure, learn through impact and check that focus disappears completely
Losing or fibrosis, calcification etc., expectorant acid fast bacteria is examined in turning negative continuously, for residual cavity, stops
After medicine, expectorant bacterium need to be turned out cloudy more than 1 year continuously, pleuritis patient's hydrothorax fully absorbs；
Effective: the cough of patient, heating, hematemesis transference cure, absorb bright through imaging examination focus
Aobvious, void closing or reduce more than 3 months, the inspection of expectorant acid fast bacteria is negative；
Effective: the cough of patient, heating, hematemesis transference cure, absorb bright through imaging examination focus
Showing or be not changed in, the inspection of expectorant acid fast bacteria turns negative continuously；
Invalid: the symptom of patient does not has any improvement or adds attention；
Deteriorating: the expectorant bacterium sun of patient turns, pathological changes increases, cavity increases or new cavity occurs；
Recurrence: after 1 course for the treatment of terminates, if during check in a year expectorant bacterium turned out cloudy sun again turn or
New focus is had to occur being considered as.
Total effective rate=(recovery from illness+effective+effectively)/total number of cases * 100%.
1.4 statistical analysis uses spss13.0 statistics software that data are carried out statistical analysis, adopt
Use x2Inspection enumeration data, with P < 0.05 for statistical significance standard.
2 results
One month terminates:
Having 24 examples to cure in treatment group, 20 examples are effective, and 1 example is effective, total effective rate 97.8%, the course for the treatment of
Check in latter 1 year is without 1 example recurrence；
Matched group has 0 example to cure, and 12 examples are effective, and 25 examples are effective, total effective rate 82.2%, two groups of ratios
Relatively treatment group is better than matched group on total effective rate, has significant difference (P < 0.05).
After 12 months:
Matched group has 25 examples to cure, and 20 examples are effective, total effective rate 100%, 1 year check nothing after the course for the treatment of
1 example recurrence.Two groups of comparison therapy groups and matched group, do not have significant difference, check in 1 year after the course for the treatment of
Without 1 example recurrence.
The effect for the treatment of group and matched group are suitable, but the treatment time for the treatment of group is far smaller than comparison
Group.
Claims (3)
1. treat phthisical pharmaceutical composition, it is characterised in that this pharmaceutical composition is by following
The raw material of weight portion is made:
Cinnabaris 8-12 part, Radix Stemonae 8-12 part, Semen Armeniacae Amarum 8-12 part, Radix Ginseng 8-12 part, Radix Gentianae Macrophyllae 8-12
Part, Carapax Trionycis (processed) 10-14 part, Radix Asparagi 10-14 part, Radix Astragali 5-7 part, Radix Platycodi (Radix Platycodonis) 5-7 part, Herba Plantaginis
8-12 part, Herba Houttuyniae 8-12 part, Nodus Nelumbinis Rhizomatis 10-14 part, Cacumen Platycladi 8-12 part, raw Folium Nelumbinis 8-12
Part, Radix Sanguisorbae 8-12 part.
The phthisical pharmaceutical composition for the treatment of the most according to claim 1, it is characterised in that:
This pharmaceutical composition is made up of the raw material of following weight parts:
10 parts of Cinnabaris, the Radix Stemonae 10 parts, 10 parts of Semen Armeniacae Amarum, Radix Ginseng 10 parts, Radix Gentianae Macrophyllae 10 parts, process Trionyx sinensis Wiegmann
First 12 parts, Radix Asparagi 12 parts, the Radix Astragali 6 parts, Radix Platycodi (Radix Platycodonis) 6 parts, Herba Plantaginis 10 parts, Herba Houttuyniae 10 parts,
Nodus Nelumbinis Rhizomatis 12 parts, Cacumen Platycladi 10 parts, raw 10 parts of Folium Nelumbinis, Radix Sanguisorbae 10 parts.
3. the pharmaceutical composition according to any one of claim 1-2 treats phthisical medicine in preparation
Application in thing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610351509.XA CN105797032A (en) | 2016-05-24 | 2016-05-24 | Medicinal composition for treating pulmonary tuberculosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610351509.XA CN105797032A (en) | 2016-05-24 | 2016-05-24 | Medicinal composition for treating pulmonary tuberculosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105797032A true CN105797032A (en) | 2016-07-27 |
Family
ID=56452862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610351509.XA Pending CN105797032A (en) | 2016-05-24 | 2016-05-24 | Medicinal composition for treating pulmonary tuberculosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105797032A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593587A (en) * | 2004-06-28 | 2005-03-16 | 黄资源 | Lung nourishing and regulating pills for the lung pattern disease and its preparation method |
| CN101125187A (en) * | 2007-08-20 | 2008-02-20 | 刘杰力 | Traditional Chinese medicinal plaster for treating pulmonary tuberculosis |
| CN103446505A (en) * | 2013-07-26 | 2013-12-18 | 杨德俊 | Traditional Chinese medicine composition for treating tuberculosis |
| CN103656406A (en) * | 2013-11-21 | 2014-03-26 | 蒋学 | Medicine for treating phthisis and preparation method of medicine |
| CN105535626A (en) * | 2016-01-18 | 2016-05-04 | 青岛市市立医院 | Traditional Chinese medicine for treating tuberculosis by combination with anti-tuberculosis western medicine |
-
2016
- 2016-05-24 CN CN201610351509.XA patent/CN105797032A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593587A (en) * | 2004-06-28 | 2005-03-16 | 黄资源 | Lung nourishing and regulating pills for the lung pattern disease and its preparation method |
| CN101125187A (en) * | 2007-08-20 | 2008-02-20 | 刘杰力 | Traditional Chinese medicinal plaster for treating pulmonary tuberculosis |
| CN103446505A (en) * | 2013-07-26 | 2013-12-18 | 杨德俊 | Traditional Chinese medicine composition for treating tuberculosis |
| CN103656406A (en) * | 2013-11-21 | 2014-03-26 | 蒋学 | Medicine for treating phthisis and preparation method of medicine |
| CN105535626A (en) * | 2016-01-18 | 2016-05-04 | 青岛市市立医院 | Traditional Chinese medicine for treating tuberculosis by combination with anti-tuberculosis western medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104367796B (en) | A kind of Chinese medicine composition for treating canker sore | |
| CN101670011A (en) | Medicament for treating rheumatism and rheumatoid and preparation method thereof | |
| CN102671088A (en) | Traditional Chinese medicine combination for treating tuberculosis | |
| CN106138668B (en) | A kind of Chinese medicine composition and preparation method thereof for treating Chronic Obstructive Pulmonary Disease | |
| CN104208473A (en) | Traditional Chinese medicine composition for treating wind-heat type cough and asthma and use thereof | |
| CN104398733B (en) | A kind of Chinese medicine preparation for treating caused by hepatic stagnation qi stagnation thyroid cancer | |
| CN100386106C (en) | Medicine for treating acne and its preparation | |
| CN101073657B (en) | 'Traditional Chinese-medicinal preparation for treating oral ulcers | |
| CN106110124A (en) | A kind of antituberculotic Chinese medicine composition | |
| CN105797032A (en) | Medicinal composition for treating pulmonary tuberculosis | |
| CN104547642A (en) | Tradtional Chinese medicine composition for treating female fibromyalgia syndromes | |
| CN103893488A (en) | Chinese medicine preparation for treating migraine and preparation method thereof | |
| CN107349336A (en) | Enriching yin supports lung and treats phthisical Chinese medicine composition and preparation method thereof | |
| CN104013728B (en) | Chinese medicine preparation of a kind of Treatment of Herpes Zoster and preparation method thereof | |
| CN115837065B (en) | Traditional Chinese medicine composition and application thereof | |
| CN105963451A (en) | Traditional Chinese medicine composition for treating pulmonary tuberculosis | |
| CN107744580A (en) | Dysmenorrhoea Chinese medicine preparation and preparation method thereof | |
| CN102406913A (en) | Chinese medicinal composition for treating melancholia | |
| CN105853704A (en) | Medicine composition for treating tuberculosis | |
| CN102626503B (en) | Chinese medicinal oral liquid for smoothing heart and enhancing intelligence | |
| CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
| CN106668669A (en) | Traditional Chinese medicine formula for treating cough variant asthma | |
| CN1739704B (en) | Chinese medicine oral liquid specially for treating tonsillitis | |
| CN104825919B (en) | A kind of herb liquid for treating AIDS fever | |
| CN103768573B (en) | A kind of spleen-stomach deficiency-cold eye for the treatment of is shed tears the Chinese medicine composition of pruritus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160727 |